TIRZAGLIX
Tirzepatide 10mg 20mg 30mg 40mg 50mg 60mg
Tirzepatide is a dual GIP and GLP-1 receptor agonist designed to support weight management, improve metabolic health, and enhance overall wellness.
Multi-GIP/GLP-1 Receptor Agonist
Targets both GIP and GLP-1 receptors for superior metabolic benefits.
Supports Weight Management
Clinically shown to promote significant weight loss by reducing appetite and improving insulin sensitivity.
Improves Metabolic Health
Helps regulate blood sugar, enhance lipid profile and support cardiovascular health.
Pharmaceutical Grade
Produced in FDA-registered facilities with the highest quality standards.
Product Description
Tirzepatide is a novel dual GIP and GLP-1 receptor agonitst that works synergistically to regulate appetite, improve glycemic control, and support significat weight loss.
For Subcutaneous use only.
Key Benefits
-
Promotes significant weight loss
-
Reduces appetite an food cravings.
-
Improves insulin sensitivity
-
Supports healthy blood sugar levels.
-
Enhances energy and overall well-being
-
Advanced dual-action mechanism.
Product Details
Active Ingredient: Tirzepatide
Concentration : 10mg, 20mg, 30mg, 40mgh, 50mg, 60mg.
Form: AqPen
Use: Subcutanous injection
Storage: Refrigerate.
Manufactured in : USA